title: Securing the future of drug discovery for central nervous system disorders.
abstract: Innovative partnerships among researchers, patients, regulators, payors and industry are needed to reinvigorate drug discovery for central nervous system disorders. Here, we summarize plans of the Collegium Internationale Neuro-Psychopharmacologicum (CINP) to achieve this goal.
authors.affiliation: Innovation Fund Denmark, Østergade 26a, DK–1100 København K, Copenhagen, Denmark. peter.hongaard@innofond.dk
authors.forename: Peter Høngaard
authors.initials: PH
authors.lastname: Andersen
authors.forename: Richard
authors.initials: R
authors.lastname: Moscicki
authors.forename: Barbara
authors.initials: B
authors.lastname: Sahakian
authors.forename: Rémi
authors.initials: R
authors.lastname: Quirion
authors.forename: Ranga
authors.initials: R
authors.lastname: Krishnan
authors.forename: Tim
authors.initials: T
authors.lastname: Race
authors.forename: Anthony
authors.initials: A
authors.lastname: Phillips
mesh_terms: D000818:Animals; D001955:British Columbia; D002491:Central Nervous System Agents / Q000627:therapeutic use*; D002493:Central Nervous System Diseases / Q000175:diagnosis / Q000188:drug therapy*; D055808:Drug Discovery / Q000639:trends*; D005544:Forecasting; D006801:Humans
chemical_list: D002491:Central Nervous System Agents